| Year |
Citation |
Score |
| 2020 |
Rohan VS, Pilch N, Moussa O, Nadig SN, Dubay D, Baliga PK, Taber DJ. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. Journal of the American College of Surgeons. 230: 373-379. PMID 32035182 DOI: 10.1016/J.Jamcollsurg.2019.12.031 |
0.301 |
|
| 2016 |
Rohan VS, Taber DJ, Moussa O, Pilch NA, Denmark S, Meadows HB, McGillicuddy JW, Chavin KD, Baliga PK, Bratton CF. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Experimental and Clinical Transplantation : Official Journal of the Middle East Society For Organ Transplantation. PMID 27267614 DOI: 10.6002/Ect.2015.0274 |
0.334 |
|
| 2016 |
Twombley K, Kavarana M, Savage A, Waslaske S, Moussa O. OR14 HLA class I antibodies increased WNT/β-catenin pathway component protein lymphoid-binding factor 1 (LEF1) in endothelial cells in foxo1 protein dependent fashion Human Immunology. 77: 12. DOI: 10.1016/J.Humimm.2016.07.026 |
0.384 |
|
| 2014 |
Sobolesky PM, Halushka PV, Garrett-Mayer E, Smith MT, Moussa O. Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancer. Plos One. 9: e107530. PMID 25202904 DOI: 10.1371/Journal.Pone.0107530 |
0.394 |
|
| 2014 |
Butts RJ, Scheurer MA, Atz AM, Moussa O, Burnette AL, Hulsey TC, Savage AJ. Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival. Circulation. Heart Failure. 7: 605-611. PMID 24833649 DOI: 10.1161/Circheartfailure.113.001008 |
0.321 |
|
| 2014 |
Sobolesky PM, Halushka PV, Garrett-Mayer E, Smith MT, Moussa O. Expression of mutant FOXO3 3A attenuated TP agonist mediated migration of UMUC3 cells. Plos One. DOI: 10.1371/Journal.Pone.0107530.G005 |
0.301 |
|
| 2014 |
Sobolesky PM, Halushka PV, Garrett-Mayer E, Moussa O. Abstract 3392: Thromboxane-A2receptor β-isoform regulates the activity of the tumor suppressor FOXO3 via phosphorylation by ERK in urothelial cancer Cancer Research. 74: 3392-3392. DOI: 10.1158/1538-7445.Am2014-3392 |
0.379 |
|
| 2014 |
Thompson T, Waslaske SH, Gimlin D, Marchman CG, McPherson EM, Titchner H, Lemerise C, Nasse C, Cellars KA, Moussa O. P031 : No More Pooled Positive Control Serum: Positive Control Serum For The Standardization Of Hla Laboratory Assays Using A Combination Of Chimeric Monoclonal Antibodies Against Hla And Ab Negative Serum Human Immunology. 75: 70. DOI: 10.1016/J.Humimm.2014.08.093 |
0.31 |
|
| 2014 |
Butts RJ, Savage AJ, Nietert PJ, Kavarana M, Moussa O, Burnette AL, Atz AM. Effect of human leukocyte antigen-C and -DQ matching on pediatric heart transplant graft survival Journal of Heart and Lung Transplantation. 33: 1282-1287. DOI: 10.1016/J.Healun.2014.07.014 |
0.333 |
|
| 2014 |
Butts R, Atz A, Scheurer M, Kavarana M, Moussa O, Burnette A, Savage A. Effect of HLA-C and DQ matching on Pediatric Heart Transplant Graft Survival Journal of Heart and Lung Transplantation. 33: 1282. DOI: 10.1016/J.Healun.2014.01.403 |
0.306 |
|
| 2013 |
Sobolesky PM, Moussa O. The role of β-arrestins in cancer. Progress in Molecular Biology and Translational Science. 118: 395-411. PMID 23764062 DOI: 10.1016/B978-0-12-394440-5.00015-2 |
0.415 |
|
| 2013 |
Sobolesky PM, Zhou T, Gorstein A, Woolworth JA, Moussa O. Abstract 4070: β-arrestin-2 mediated regulation of plasminogen activator inhibitor Type 1. Cancer Research. 73: 4070-4070. DOI: 10.1158/1538-7445.Am2013-4070 |
0.407 |
|
| 2013 |
Waslaske SH, Nasse C, Thompson T, Marchman CG, McPherson EM, Moussa O. 35-P: Postive Flow Cytometry Crosmmatch Due To Low Levels Of Non-Self Pan A Locus Antibody: Characterized By Biological And Bioinformatical Approaches Human Immunology. 74: 73. DOI: 10.1016/J.Humimm.2013.08.110 |
0.346 |
|
| 2012 |
Waslaske SH, Nickels L, Nasse CL, Titchener EH, Cellars KA, Savage AJ, Moussa O. 52-P: Cardiac Transplantation Of Highly Sensitized Patients Across C1Q Negative Hla Antibodies Human Immunology. 73: 82. DOI: 10.1016/J.Humimm.2012.07.178 |
0.356 |
|
| 2012 |
Marchman CG, Waslaske SH, Hagy C, Pinckney AM, McPherson EM, Thompson TG, Moussa O. 37-P: Formation Of Hla Antibodies In Non-Sensitized Patients After Immediate Graft Loss For Non-Immunological Causes Human Immunology. 73: 73. DOI: 10.1016/J.Humimm.2012.07.163 |
0.331 |
|
| 2011 |
Moussa O, Ciupek A, Watson DK, Halushka PV. Urinary thromboxane B2 and thromboxane receptors in bladder cancer: Opportunity for detection and monitoring Prostaglandins and Other Lipid Mediators. 96: 41-44. PMID 21983220 DOI: 10.1016/J.Prostaglandins.2011.09.002 |
0.359 |
|
| 2011 |
Findlay VJ, Turner DP, Yordy JS, McCarragher B, Shriver MR, Szalai G, Watson PM, Larue AC, Moussa O, Watson DK. Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. Genes & Cancer. 2: 120-9. PMID 21779485 DOI: 10.1177/1947601911410424 |
0.359 |
|
| 2011 |
Turner DP, Findlay VJ, Moussa O, Semenchenko VI, Watson PM, Larue AC, Desouki MM, Fraig M, Watson DK. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression Prostate. 71: 1723-1735. PMID 21446014 DOI: 10.1002/Pros.21389 |
0.373 |
|
| 2010 |
Costa LJ, Moussa O, Bray RA, Stuart RK. Overcoming HLA-DPB1 donor specific antibody-mediated haematopoietic graft failure. British Journal of Haematology. 151: 94-6. PMID 20636435 DOI: 10.1111/J.1365-2141.2010.08305.X |
0.323 |
|
| 2010 |
Findlay VJ, Watson PM, Feldman RJ, Sigmon SA, Gong YZ, Moussa O, Sypropoulos DD, Turner DP, Watson DK. Abstract 3397: The role ofPdefin mammary development, tumorigenesis and metastasis Cancer Research. 70: 3397-3397. DOI: 10.1158/1538-7445.Am10-3397 |
0.356 |
|
| 2010 |
Woolworth JA, Watson D, Halushka PV, Moussa O. Abstract 3196: The role of Ga12 and Thromboxane receptor beta interaction in bladder cancer progression Cancer Research. 70: 3196-3196. DOI: 10.1158/1538-7445.Am10-3196 |
0.393 |
|
| 2010 |
Woolworth JA, Desouki M, Halushka P, Watson D, Smith MT, Moussa O. Abstract B26: The role of G alpha12 and thromboxane receptor beta interaction in bladder cancer progression Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-B26 |
0.383 |
|
| 2009 |
Moussa O, Turner DP, Feldman RJ, Sementchenko VI, McCarragher BD, Desouki MM, Fraig M, Watson DK. PDEF is a negative regulator of colon cancer cell growth and migration. Journal of Cellular Biochemistry. 108: 1389-98. PMID 19830706 DOI: 10.1002/Jcb.22371 |
0.409 |
|
| 2009 |
Shirai K, Sera Y, Bulkeley W, Mehrotra M, Moussa O, LaRue AC, Watson DK, Stuart RK, Lazarchick J, Ogawa M. Hematopoietic stem cell origin of human fibroblasts: Cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia Experimental Hematology. 37: 1464-1471. PMID 19786066 DOI: 10.1016/J.Exphem.2009.09.008 |
0.317 |
|
| 2009 |
Sera Y, LaRue AC, Moussa O, Mehrotra M, Duncan JD, Williams CR, Nishimoto E, Schulte BA, Watson PM, Watson DK, Ogawa M. Hematopoietic stem cell origin of adipocytes. Experimental Hematology. 37: 1108-20, 1120.e1-4. PMID 19576951 DOI: 10.1016/J.Exphem.2009.06.008 |
0.305 |
|
| 2009 |
Gebel HM, Moussa O, Eckels DD, Bray RA. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. Human Immunology. 70: 610-7. PMID 19375473 DOI: 10.1016/J.Humimm.2009.04.012 |
0.351 |
|
| 2009 |
Waslaske SH, Gates DA, Nasse CB, Bray RA, Gebel HM, Moussa O. 46-P: Evaluation of the whole genome amplification procedure in routine HLA typing of stem cells transplantation candidates Human Immunology. 70. DOI: 10.1016/J.Humimm.2009.09.079 |
0.306 |
|
| 2008 |
Findlay VJ, Turner DP, Moussa O, Watson DK. MicroRNA-mediated inhibition of prostate-derived ets factor messenger RNA translation affects prostate-derived ets factor regulatory networks in human breast cancer Cancer Research. 68: 8499-8506. PMID 18922924 DOI: 10.1158/0008-5472.Can-08-0907 |
0.375 |
|
| 2008 |
Zhang XK, Moussa O, Larue A, Bradshaw S, Molano I, Spyropoulos DD, Gilkeson GS, Watson DK. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice Journal of Immunology. 181: 1644-1654. PMID 18641300 DOI: 10.4049/Jimmunol.181.3.1644 |
0.328 |
|
| 2008 |
Turner DP, Findlay VJ, Kirven AD, Moussa O, Watson DK. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression Molecular Biology of the Cell. 19: 3745-3757. PMID 18579687 DOI: 10.1091/Mbc.E08-02-0154 |
0.409 |
|
| 2008 |
Moussa O, Ashton AW, Fraig M, Garrett-Mayer E, Ghoneim MA, Halushka PV, Watson DK. Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Research. 68: 4097-104. PMID 18519668 DOI: 10.1158/0008-5472.Can-07-6560 |
0.387 |
|
| 2008 |
Moussa O, Riker JM, Klein J, Fraig M, Halushka PV, Watson DK. Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents Oncogene. 27: 55-62. PMID 17603559 DOI: 10.1038/Sj.Onc.1210629 |
0.399 |
|
| 2007 |
Turner DP, Findlay VJ, Moussa O, Watson DK. Defining ETS transcription regulatory networks and their contribution to breast cancer progression Journal of Cellular Biochemistry. 102: 549-559. PMID 17661355 DOI: 10.1002/Jcb.21494 |
0.361 |
|
| 2007 |
Turner DP, Moussa O, Sauane M, Fisher PB, Watson DK. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer Cancer Research. 67: 1618-1625. PMID 17308102 DOI: 10.1158/0008-5472.Can-06-2913 |
0.37 |
|
| 2006 |
Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. The Journal of Urology. 175: 2312-6. PMID 16697865 DOI: 10.1016/S0022-5347(06)00254-0 |
0.34 |
|
| 2005 |
Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Halushka PV, Ghoneim MA, Watson DK. Prognostic and Functional Significance of Thromboxane Synthase Gene Overexpression in Invasive Bladder Cancer Cancer Research. 65: 11581-11587. PMID 16357168 DOI: 10.1158/0008-5472.Can-05-1622 |
0.392 |
|
| 2005 |
Yordy JS, Moussa O, Pei H, Chaussabel D, Li R, Watson DK. SP100 inhibits ETS1 activity in primary endothelial cells Oncogene. 24: 916-931. PMID 15592518 DOI: 10.1038/Sj.Onc.1208245 |
0.309 |
|
| 2005 |
Masuya M, Moussa O, Abe T, Deguchi T, Higuchi T, Ebihara Y, Spyropoulos DD, Watson DK, Ogawa M. Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Blood. 105: 95-102. PMID 15367440 DOI: 10.1182/Blood-2003-12-4345 |
0.335 |
|
| 2004 |
Jackers P, Szalai G, Moussa O, Watson DK. Ets-dependent regulation of target gene expression during megakaryopoiesis Journal of Biological Chemistry. 279: 52183-52190. PMID 15466856 DOI: 10.1074/Jbc.M407489200 |
0.339 |
|
| Show low-probability matches. |